Novocure
Kassie Balestrieri, PhD, is a Clinical Research Scientist at Novocure since December 2022, previously serving as a Clinical Research Scientist II and Clinical Development Scientist at Axogen from January 2021 to December 2022. Prior experience includes working as an Alliance and Program Coordinator at Lacerta Therapeutics from January 2020 to January 2021, and holding positions such as Senior Associate Quality Assurance and Specialist in Quality Systems & Standards at Pfizer from September 2007 to August 2014. Kassie Balestrieri holds a Doctor of Philosophy in Oncology and Cancer Biology from The Brody School of Medicine at East Carolina University, a Master's degree in Biological and Biomedical Sciences from Washington University in St. Louis, and a Bachelor of Science in Biological and Biomedical Sciences from Southern Illinois University Edwardsville.
This person is not in any offices
Novocure
3 followers
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma.